Increased Fracture Risk in Women Treated With Aromatase Inhibitors Versus Tamoxifen: Beneficial Effect of Bisphosphonates.
Increased Fracture Risk in Women Treated With Aromatase Inhibitors Versus Tamoxifen: Beneficial Effect of Bisphosphonates.
Increased Fracture Risk in Women Treated With Aromatase Inhibitors Versus Tamoxifen: Beneficial Effect of Bisphosphonates.
Phosphate disorders and clinical management of hypophosphatemia and hyperphosphatemia
Effects of Therapeutic Doses of Celecoxib on Several Physiological Parameters of Cultured Human Osteoblasts
The osteocyte: A multifunctional cell within the bone
Hip fractures following denosumab discontinuation: three clinical cases reports
A subset of low density granulocytes is associated with vascular calcification in chronic kidney disease patients
Fracture liaison service and mortality in elderly hip fracture patients: a prospective cohort study
Analysis of volumetric BMD in people with Down syndrome using DXA-based 3D modeling
Zoledronate in the prevention of Paget’s (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget’s disease of bone